| NTG | Name: | 5-(1,4-oxazepan-4-yl)pyridine-2-carbonitrile | Formula: | C11 H13 N3 O | SMILES: | N#Cc2ncc(N1CCCOCC1)cc2 | InChi: | InChI=1S/C11H13N3O/c12-8-10-2-3-11(9-13-10)14-4-1-6-15-7-5-14/h2-3,9H,1,4-7H2 | Definition date: | 2019-05-28 | Last modified: | 2019-08-02 | Release date: | 2019-08-07 | Identifier: | 5-(1,4-oxazepan-4-yl)pyridine-2-carbonitrile |
|
| NTV | Name: | (2S)-N-(3-chloro-2-methylphenyl)oxolane-2-carboxamide | Formula: | C12 H14 Cl N O2 | SMILES: | N(C(=O)C1CCCO1)c2cccc(c2C)Cl | InChi: | InChI=1S/C12H14ClNO2/c1-8-9(13)4-2-5-10(8)14-12(15)11-6-3-7-16-11/h2,4-5,11H,3,6-7H2,1H3,(H,14,15)/t11-/m0/s1 | Definition date: | 2019-05-28 | Last modified: | 2019-08-02 | Release date: | 2019-08-07 | Identifier: | (2S)-N-(3-chloro-2-methylphenyl)oxolane-2-carboxamide |
|
| NU4 | Name: | 2-methyl-N-(pyridin-4-yl)furan-3-carboxamide | Formula: | C11 H10 N2 O2 | SMILES: | N(c1ccncc1)C(c2ccoc2C)=O | InChi: | InChI=1S/C11H10N2O2/c1-8-10(4-7-15-8)11(14)13-9-2-5-12-6-3-9/h2-7H,1H3,(H,12,13,14) | Definition date: | 2019-05-28 | Last modified: | 2019-08-02 | Release date: | 2019-08-07 | Identifier: | 2-methyl-N-(pyridin-4-yl)furan-3-carboxamide |
|
| NUJ | Name: | trans-3-[(2,6-dimethylpyrimidin-4-yl)(methyl)amino]cyclobutan-1-ol | Formula: | C11 H17 N3 O | SMILES: | N(c1nc(C)nc(c1)C)(C)C2CC(C2)O | InChi: | InChI=1S/C11H17N3O/c1-7-4-11(13-8(2)12-7)14(3)9-5-10(15)6-9/h4,9-10,15H,5-6H2,1-3H3/t9-,10- | Definition date: | 2019-05-28 | Last modified: | 2019-08-02 | Release date: | 2019-08-07 | Identifier: | trans-3-[(2,6-dimethylpyrimidin-4-yl)(methyl)amino]cyclobutan-1-ol |
|
| NUM | Name: | N-[2-(4-hydroxyphenyl)ethyl]pyridine-2-carboxamide | Formula: | C14 H14 N2 O2 | SMILES: | N(C(c1ccccn1)=O)CCc2ccc(cc2)O | InChi: | InChI=1S/C14H14N2O2/c17-12-6-4-11(5-7-12)8-10-16-14(18)13-3-1-2-9-15-13/h1-7,9,17H,8,10H2,(H,16,18) | Definition date: | 2019-05-28 | Last modified: | 2019-08-02 | Release date: | 2019-08-07 | Identifier: | N-[2-(4-hydroxyphenyl)ethyl]pyridine-2-carboxamide |
|
| NV7 | Name: | 1-[(furan-2-yl)methyl]-4-(methylsulfonyl)piperazine | Formula: | C10 H16 N2 O3 S | SMILES: | N2(CCN(Cc1occc1)CC2)S(C)(=O)=O | InChi: | InChI=1S/C10H16N2O3S/c1-16(13,14)12-6-4-11(5-7-12)9-10-3-2-8-15-10/h2-3,8H,4-7,9H2,1H3 | Definition date: | 2019-05-28 | Last modified: | 2019-08-02 | Release date: | 2019-08-07 | Identifier: | 1-[(furan-2-yl)methyl]-4-(methylsulfonyl)piperazine |
|
| NVD | Name: | N-{[4-(dimethylamino)phenyl]methyl}-4H-1,2,4-triazol-4-amine | Formula: | C11 H15 N5 | SMILES: | N(C)(C)c2ccc(CNn1cnnc1)cc2 | InChi: | InChI=1S/C11H15N5/c1-15(2)11-5-3-10(4-6-11)7-14-16-8-12-13-9-16/h3-6,8-9,14H,7H2,1-2H3 | Definition date: | 2019-05-28 | Last modified: | 2019-08-02 | Release date: | 2019-08-07 | Identifier: | N-{[4-(dimethylamino)phenyl]methyl}-4H-1,2,4-triazol-4-amine |
|
| NVJ | Name: | ethyl benzylcarbamate | Formula: | C10 H13 N O2 | SMILES: | N(Cc1ccccc1)C(=O)OCC | InChi: | InChI=1S/C10H13NO2/c1-2-13-10(12)11-8-9-6-4-3-5-7-9/h3-7H,2,8H2,1H3,(H,11,12) | Definition date: | 2019-05-28 | Last modified: | 2019-08-02 | Release date: | 2019-08-07 | Identifier: | ethyl benzylcarbamate |
|
| NVM | Name: | [(4R)-4-methyl-2,3,4,5-tetrahydro-1H-azepin-1-yl](1,3-thiazol-4-yl)methanone | Formula: | C11 H14 N2 O S | SMILES: | N1(CCC(C)CC=C1)C(=O)c2cscn2 | InChi: | InChI=1S/C11H14N2OS/c1-9-3-2-5-13(6-4-9)11(14)10-7-15-8-12-10/h2,5,7-9H,3-4,6H2,1H3/t9-/m1/s1 | Definition date: | 2019-05-28 | Last modified: | 2019-08-02 | Release date: | 2019-08-07 | Identifier: | [(4R)-4-methyl-2,3,4,5-tetrahydro-1H-azepin-1-yl](1,3-thiazol-4-yl)methanone |
|
| NW4 | Name: | 3-cyclohexyl-1-(morpholin-4-yl)propan-1-one | Formula: | C13 H23 N O2 | SMILES: | N1(CCOCC1)C(=O)CCC2CCCCC2 | InChi: | InChI=1S/C13H23NO2/c15-13(14-8-10-16-11-9-14)7-6-12-4-2-1-3-5-12/h12H,1-11H2 | Definition date: | 2019-05-28 | Last modified: | 2019-08-02 | Release date: | 2019-08-07 | Identifier: | 3-cyclohexyl-1-(morpholin-4-yl)propan-1-one |
|
| NW7 | Name: | 3-ethyl-5-methyl-N-(5-methyl-1,2-oxazol-3-yl)-1,2-oxazole-4-carboxamide | Formula: | C11 H13 N3 O3 | SMILES: | n2oc(C)c(C(Nc1noc(c1)C)=O)c2CC | InChi: | InChI=1S/C11H13N3O3/c1-4-8-10(7(3)17-13-8)11(15)12-9-5-6(2)16-14-9/h5H,4H2,1-3H3,(H,12,14,15) | Definition date: | 2019-05-28 | Last modified: | 2019-08-02 | Release date: | 2019-08-07 | Identifier: | 3-ethyl-5-methyl-N-(5-methyl-1,2-oxazol-3-yl)-1,2-oxazole-4-carboxamide |
|
| NZM | Name: | cefixime, bound form | Formula: | C16 H17 N5 O7 S2 | SMILES: | OC(=O)CON=C(/C(=O)NC(C=O)C1SCC(=C(N1)C(O)=O)[C@H]=C)c2csc(N)n2 | InChi: | InChI=1S/C16H17N5O7S2/c1-2-7-5-29-14(20-11(7)15(26)27)8(3-22)18-13(25)12(21-28-4-10(23)24)9-6-30-16(17)19-9/h2-3,6,8,14,20H,1,4-5H2,(H2,17,19)(H,18,25)(H,23,24)(H,26,27)/b21-12-/t8-,14-/m1/s1 | Definition date: | 2019-05-30 | Last modified: | 2019-08-02 | Release date: | 2019-08-07 | Identifier: | (2R)-2-[(1R)-1-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetyl}amino)-2-oxoethyl]-5-ethenyl-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid |
|
| NZV | Name: | ceftriaxone, bound form | Formula: | C18 H20 N8 O8 S3 | SMILES: | O=C(/C(c1csc(N)n1)=NOC)NC(C(O)=O)C2SCC(=C(N2)C(O)=O)CSC=3N(NC(C(N=3)=O)=O)C | InChi: | InChI=1S/C18H20N8O8S3/c1-26-18(23-12(28)13(29)24-26)37-4-6-3-35-14(22-8(6)15(30)31)10(16(32)33)21-11(27)9(25-34-2)7-5-36-17(19)20-7/h5,10,14,22H,3-4H2,1-2H3,(H2,19,20)(H,21,27)(H,24,29)(H,30,31)(H,32,33)/b25-9-/t10-,14+/m0/s1 | Definition date: | 2019-05-30 | Last modified: | 2019-08-02 | Release date: | 2019-08-07 | Identifier: | (2R)-2-[(R)-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}(carboxy)methyl]-5-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid |
|
| HVY | Name: | N-(2-chloro-6-methylphenyl)-2-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-4-{[2-(propanoylamino)phenyl]amino}pyrimidine-5-carboxamide | Formula: | C32 H35 Cl N8 O2 | SMILES: | CN5CCN(c1ccc(cc1)Nc2nc(c(cn2)C(=O)Nc3c(cccc3C)Cl)Nc4c(cccc4)NC(=O)CC)CC5 | InChi: | InChI=1S/C32H35ClN8O2/c1-4-28(42)36-26-10-5-6-11-27(26)37-30-24(31(43)38-29-21(2)8-7-9-25(29)33)20-34-32(39-30)35-22-12-14-23(15-13-22)41-18-16-40(3)17-19-41/h5-15,20H,4,16-19H2,1-3H3,(H,36,42)(H,38,43)(H2,34,35,37,39) | Definition date: | 2018-07-26 | Last modified: | 2019-07-26 | Release date: | 2019-07-31 | Identifier: | N-(2-chloro-6-methylphenyl)-2-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-4-{[2-(propanoylamino)phenyl]amino}pyrimidine-5-carboxamide |
|
| HWA | Name: | 3-hydroxy-6-methyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid | Formula: | C7 H7 N O4 | SMILES: | OC(=O)C=1NC(C)=CC(C=1O)=O | InChi: | InChI=1S/C7H7NO4/c1-3-2-4(9)6(10)5(8-3)7(11)12/h2,10H,1H3,(H,8,9)(H,11,12) | Definition date: | 2018-07-26 | Last modified: | 2019-07-26 | Release date: | 2019-07-31 | Identifier: | 3-hydroxy-6-methyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid |
|
| HWJ | Name: | 3-hydroxy-6-[2-methyl-4-(1H-tetrazol-5-yl)phenyl]-4-oxo-1,4-dihydropyridine-2-carboxylic acid | Formula: | C14 H11 N5 O4 | SMILES: | O=C(O)C=1NC(=CC(C=1O)=O)c2ccc(cc2C)c3nnnn3 | InChi: | InChI=1S/C14H11N5O4/c1-6-4-7(13-16-18-19-17-13)2-3-8(6)9-5-10(20)12(21)11(15-9)14(22)23/h2-5,21H,1H3,(H,15,20)(H,22,23)(H,16,17,18,19) | Definition date: | 2018-07-26 | Last modified: | 2019-07-26 | Release date: | 2019-07-31 | Identifier: | 3-hydroxy-6-[2-methyl-4-(1H-tetrazol-5-yl)phenyl]-4-oxo-1,4-dihydropyridine-2-carboxylic acid |
|
| HWM | Name: | 5-hydroxy-2-methyl-1-[4-(1H-tetrazol-5-yl)phenyl]pyridin-4(1H)-one | Formula: | C13 H11 N5 O2 | SMILES: | n1nnnc1c2ccc(cc2)N3C(=CC(C(=C3)O)=O)C | InChi: | InChI=1S/C13H11N5O2/c1-8-6-11(19)12(20)7-18(8)10-4-2-9(3-5-10)13-14-16-17-15-13/h2-7,20H,1H3,(H,14,15,16,17) | Definition date: | 2018-07-26 | Last modified: | 2019-07-26 | Release date: | 2019-07-31 | Identifier: | 5-hydroxy-2-methyl-1-[4-(1H-tetrazol-5-yl)phenyl]pyridin-4(1H)-one |
|
| HWV | Name: | N-ethyl-4-[2-(4-fluoro-2,6-dimethylphenoxy)-5-(2-hydroxypropan-2-yl)phenyl]-6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridine-2-carboxamide | Formula: | C28 H30 F N3 O4 | SMILES: | N2(C)C=C(c1cc(C(NCC)=O)nc1C2=O)c3cc(C(C)(O)C)ccc3Oc4c(cc(F)cc4C)C | InChi: | InChI=1S/C28H30FN3O4/c1-7-30-26(33)22-13-20-21(14-32(6)27(34)24(20)31-22)19-12-17(28(4,5)35)8-9-23(19)36-25-15(2)10-18(29)11-16(25)3/h8-14,31,35H,7H2,1-6H3,(H,30,33) | Definition date: | 2018-07-27 | Last modified: | 2019-07-26 | Release date: | 2019-07-31 | Identifier: | N-ethyl-4-[2-(4-fluoro-2,6-dimethylphenoxy)-5-(2-hydroxypropan-2-yl)phenyl]-6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridine-2-carboxamide |
|
| GK2 | Name: | [(2~{R})-1-[(2~{R})-2-azanyl-3-methyl-butanoyl]pyrrolidin-2-yl]boronic acid | Formula: | C9 H19 B N2 O3 | SMILES: | CC(C)[CH](N)C(=O)N1CCC[CH]1B(O)O | InChi: | InChI=1S/C9H19BN2O3/c1-6(2)8(11)9(13)12-5-3-4-7(12)10(14)15/h6-8,14-15H,3-5,11H2,1-2H3/t7-,8+/m0/s1 | Definition date: | 2018-09-19 | Last modified: | 2019-07-26 | Release date: | 2019-07-31 | Identifier: | [(2~{R})-1-[(2~{R})-2-azanyl-3-methyl-butanoyl]pyrrolidin-2-yl]boronic acid |
|
| KJ4 | Name: | N-{3-[(2Z,4S)-1-(2-{[2-(2-amino-1H-imidazol-1-yl)ethyl](methyl)amino}ethyl)-3-(3-cyclohexylpropyl)-2-iminoimidazolidin-4-yl]propyl}guanidine | Formula: | C24 H46 N10 | SMILES: | C(CCC2CN(CCN(C)CCn1ccnc1N)C(=N)N2CCCC3CCCCC3)NC(=N)N | InChi: | InChI=1S/C24H46N10/c1-31(15-17-32-14-12-30-23(32)27)16-18-33-19-21(10-5-11-29-22(25)26)34(24(33)28)13-6-9-20-7-3-2-4-8-20/h12,14,20-21,28H,2-11,13,15-19H2,1H3,(H2,27,30)(H4,25,26,29)/b28-24-/t21-/m0/s1 | Definition date: | 2018-12-11 | Last modified: | 2019-07-26 | Release date: | 2019-07-31 | Identifier: | N-{3-[(2Z,4S)-1-(2-{[2-(2-amino-1H-imidazol-1-yl)ethyl](methyl)amino}ethyl)-3-(3-cyclohexylpropyl)-2-iminoimidazolidin-4-yl]propyl}guanidine |
|
| KJ7 | Name: | (5S)-5-benzyl-4,5-dihydro-1H-imidazol-2-amine | Formula: | C10 H13 N3 | SMILES: | C=1(N)NC(CN=1)Cc2ccccc2 | InChi: | InChI=1S/C10H13N3/c11-10-12-7-9(13-10)6-8-4-2-1-3-5-8/h1-5,9H,6-7H2,(H3,11,12,13)/t9-/m0/s1 | Definition date: | 2018-12-11 | Last modified: | 2019-07-26 | Release date: | 2019-07-31 | Identifier: | (5S)-5-benzyl-4,5-dihydro-1H-imidazol-2-amine |
|
| KSZ | Name: | ~{tert}-butyl ~{N}-[3-[2-[(4~{S})-6-(4-chlorophenyl)-8-methoxy-1-methyl-4~{H}-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]ethanoylamino]propyl]carbamate | Formula: | C28 H33 Cl N6 O4 | SMILES: | COc1ccc2n3c(C)nnc3[CH](CC(=O)NCCCNC(=O)OC(C)(C)C)N=C(c4ccc(Cl)cc4)c2c1 | InChi: | InChI=1S/C28H33ClN6O4/c1-17-33-34-26-22(16-24(36)30-13-6-14-31-27(37)39-28(2,3)4)32-25(18-7-9-19(29)10-8-18)21-15-20(38-5)11-12-23(21)35(17)26/h7-12,15,22H,6,13-14,16H2,1-5H3,(H,30,36)(H,31,37)/t22-/m0/s1 | Definition date: | 2019-06-20 | Last modified: | 2019-07-26 | Release date: | 2019-07-31 | Identifier: | ~{tert}-butyl ~{N}-[3-[2-[(4~{S})-6-(4-chlorophenyl)-8-methoxy-1-methyl-4~{H}-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]ethanoylamino]propyl]carbamate |
|
| N0V | Name: | (3R)-N-[3-(2-cyclopropylpyridin-4-yl)-1H-indazol-5-yl]-3-(methoxymethyl)-1-(2-oxo-2-{4-[4-(pyrimidin-2-yl)phenyl]-3,6-dihydropyridin-1(2H)-yl}ethyl)pyrrolidine-3-carboxamide | Formula: | C39 H40 N8 O3 | SMILES: | C1CC1c2cc(ccn2)c8c7c(ccc(NC(C3(CN(CC3)CC(N4CC=C(CC4)c5ccc(cc5)c6ncccn6)=O)COC)=O)c7)nn8 | InChi: | InChI=1S/C39H40N8O3/c1-50-25-39(38(49)43-31-9-10-33-32(22-31)36(45-44-33)30-11-17-40-34(21-30)28-5-6-28)14-20-46(24-39)23-35(48)47-18-12-27(13-19-47)26-3-7-29(8-4-26)37-41-15-2-16-42-37/h2-4,7-12,15-17,21-22,28H,5-6,13-14,18-20,23-25H2,1H3,(H,43,49)(H,44,45)/t39-/m1/s1 | Definition date: | 2019-04-29 | Last modified: | 2019-07-26 | Release date: | 2019-07-31 | Identifier: | (3R)-N-[3-(2-cyclopropylpyridin-4-yl)-1H-indazol-5-yl]-3-(methoxymethyl)-1-(2-oxo-2-{4-[4-(pyrimidin-2-yl)phenyl]-3,6-dihydropyridin-1(2H)-yl}ethyl)pyrrolidine-3-carboxamide |
|
| FL5 | Name: | 12-(dimethylamino)-3,10-diethyl-N,N,N-trimethyl-3,10-dihydrodibenzo[3,4:7,8]cycloocta[1,2-d:5,6-d']bis([1,2,3]triazole)-5-aminium | Formula: | C25 H31 N8 | SMILES: | CCn1nnc2c3ccc(cc3c4n(CC)nnc4c5ccc(cc5c12)N(C)C)[N+](C)(C)C | InChi: | InChI=1S/C25H31N8/c1-8-31-24-20-14-16(30(3)4)10-12-18(20)22-25(32(9-2)29-26-22)21-15-17(33(5,6)7)11-13-19(21)23(24)27-28-31/h10-15H,8-9H2,1-7H3/q+1/b22-18+,23-19+,24-20+,25-21+ | Definition date: | 2018-07-19 | Last modified: | 2019-07-26 | Release date: | 2019-07-31 |
|
| M9J | Name: | N-(cyclobutylmethyl)-3-{5-[1-(pyrrolidin-1-yl)cyclohexyl]-2-(1-{[(2S)-pyrrolidin-2-yl]methyl}-1H-indol-5-yl)-1,3-thiazol-4-yl}prop-2-yn-1-amine | Formula: | C34 H45 N5 S | SMILES: | C1C(CCCC1)(N2CCCC2)c3sc(nc3C#CCNCC4CCC4)c6cc5ccn(c5cc6)CC7CCCN7 | InChi: | InChI=1S/C34H45N5S/c1-2-16-34(17-3-1,39-20-4-5-21-39)32-30(12-8-18-35-24-26-9-6-10-26)37-33(40-32)28-13-14-31-27(23-28)15-22-38(31)25-29-11-7-19-36-29/h13-15,22-23,26,29,35-36H,1-7,9-11,16-21,24-25H2/t29-/m0/s1 | Definition date: | 2019-03-28 | Last modified: | 2019-07-26 | Release date: | 2019-07-31 | Identifier: | N-(cyclobutylmethyl)-3-{5-[1-(pyrrolidin-1-yl)cyclohexyl]-2-(1-{[(2S)-pyrrolidin-2-yl]methyl}-1H-indol-5-yl)-1,3-thiazol-4-yl}prop-2-yn-1-amine |
|